WILMINGTON, N.C., Apr 5, 2012 (GlobeNewswire via COMTEX) — TranS1 Inc. a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that it has appointed Jeffrey Fischgrund, M.D. to serve on its Board of Directors. Dr. Fischgrund currently serves as Professor of Orthopaedic Surgery at The Oakland University School of Medicine, at William Beaumont Hospital in Royal Oak, MI.
“Jeff brings tremendous experience in the field of spinal implants as well as in the design and development of clinical studies utilized to demonstrate the safety and efficacy of many types of spinal therapies,” stated Ken Reali, President and CEO of TranS1 Inc. “TranS1 is fortunate to add a director of Dr. Fischgrund’s caliber to our Board.”Dr. Fischgrund, 51, is a board certified orthopaedic spine surgeon with over 20 years of experience. A graduate of George Washington University School of Medicine in Washington, D.C., Dr. Fischgrund completed an orthopaedic surgery residency at the University of Maryland Medical Center in Baltimore, and a spine surgery fellowship at William Beaumont Hospital in Royal Oak. He has served as the Editor in Chief of the Journal of the American Academy of Orthopaedic Surgeons since 2009, and has been the Spine Fellowship Director at Beaumont since 2008.
(Visited 16 times, 3 visits today)